Last Updated : July 24, 2024
Details
Generic Name:
dexamethasone intravitreal implant
Project Status:
Not filed
Therapeutic Area:
Non-infectious uveitis
Manufacturer:
AbbVie Corporation
Brand Name:
Ozurdex
Project Line:
Reimbursement Review
Project Number:
NS0033-000
Biosimilar:
No
Submission Type:
Non-submission
Fee Schedule:
N/A
Indications:
Treatment of non-infectious uveitis affecting the posterior segment of the eye
Recommendation Type:
Canada’s Drug Agency is unable to recommend reimbursement as a submission was not filed by the manufacturer
Last Updated : July 24, 2024